What we do Mahamaya Lifesciences Ltd manufactures pesticide and bio-stimulant formulations, serving Indian agrochemical firms and multinational corporations with domestic and global sales. |
Founded in 2,002 |
Market share Growing presence with strong client base including Atul Ltd, IFFCO-MC, and DCM Shriram in agrochemical formulations. |
Problem solved Provides eco-friendly, high-quality pesticide and bio-stimulant solutions that enhance crop productivity and sustainability for farmers. |
Top clients or who we serve Serves Indian agrochemical companies, multinational corporations, and exports to countries like UAE, Turkey, Egypt, and Dominican Republic; B2B focused. |
Key management Krishnamurthy Ganesan (Managing Director), Lalitha Krishnamurthy (Whole-time Director), Prashant Krishnamurthy (Executive Director & CFO). |
Our journey and innovations Started with pesticide molecule imports and registrations; built manufacturing in Dahej; innovated Norwegian seaweed-based bio-stimulants. |
Where we operate Operations across India with exports to Middle East, Africa, Dominican Republic, Turkey, and Egypt. |
Top products or what we offer Flagship products include Glufosinate Ammonium 13.5% SL and Emamectin 5% SG pesticides and bio-stimulant formulations. |
Top brands Glufosinate Ammonium 13.5% SL and Emamectin 5% SG are key products driving demand and revenue growth. |
Raw materials needed Active pesticide molecules and bio-based extracts like Norwegian seaweed for formulation manufacturing. |
Raw materials supplier Imports key molecules; specific suppliers not disclosed in data provided. |
Recurring vs cyclical contribution Revenue driven by ongoing bulk formulation sales and exports; mix of recurring domestic sales and export demand. |
Our industry position Emerging player with established manufacturing and approvals; expanding export footprint and client base. |
Financial highlights FY 2024-25 revenues Rs 264.15 crore, profit Rs 12.94 crore, nearly 64% revenue growth from prior year; strong EBITDA increase. |
Geographical revenue split Domestic sales across multiple Indian states; exports mainly to Middle East, Africa, Dominican Republic, Turkey, and Egypt. |
Order book - |
Whats driving growth High-quality products, new clientele, expanded manufacturing, R&D in formulations, and increased export registrations. |
Our future plans Expand export markets especially Middle East and Africa; enhance R&D for new pesticides and cost-efficient processes. |
Our green promise Focus on bio-stimulant products promoting sustainable and eco-friendly agriculture practices. |
Our people and values Committed leadership with focus on compliance, employee welfare including maternity benefits and anti-harassment policies. |
Key challenges ahead Competition, regulatory approvals, raw material sourcing, and sustaining export growth amid global market volatility. |
Interesting facts Converted from private to public limited in 2024; strong bonus share issuance in 2024; launched Norwegian seaweed bio-stimulants. |
Risks and strategy Mitigates risks via regulatory compliance, quality focus, diversification of markets, and continuous R&D investments. |
